The DOI matches its Crossref record; 174 of the 174 references it cites were found in a registry or an index.
Inflammation-associated immune suppression in cancer: The roles played by cytokines, chemokines and additional mediators
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Coussens, L. M., & Werb, Z. (2002) · Nature · doi:10.1038/nature01322 · Cited by 15,111
Free Radicals in the Physiological Control of Cell Function
Dröge, W. (2002) · Physiological Reviews · doi:10.1152/physrev.00018.2001 · Cited by 9,855
Inflammation and cancer: back to Virchow?
Balkwill, F., & Mantovani, A. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04046-0 · Cited by 7,746
Interleukin-10 and the Interleukin-10 Receptor
Moore, K. W., de Waal Malefyt, R., Coffman, R. L., & O'Garra, A. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.683 · Cited by 6,737
MANTOVANI, A., SOZZANI, S., LOCATI, M., ALLAVENA, P., & SICA, A. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(02)02302-5 · Cited by 5,528
NITRIC OXIDE AND MACROPHAGE FUNCTION
MacMicking, J., Xie, Q.-W., & Nathan, C. (1997) · Annual Review of Immunology · doi:10.1146/annurev.immunol.15.1.323 · Cited by 4,211
de Waal Malefyt, R., Abrams, J., Bennett, B., Figdor, C. G., & de Vries, J. E. (1991) · The Journal of experimental medicine · doi:10.1084/jem.174.5.1209 · Cited by 3,762
Nitric oxide and the immune response
Bogdan, C. (2001) · Nature Immunology · doi:10.1038/ni1001-907 · Cited by 3,447
Tumour-educated macrophages promote tumour progression and metastasis
Pollard, J. W. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1256 · Cited by 3,367
Production of large amounts of hydrogen peroxide by human tumor cells.
Szatrowski, T. P., & Nathan, C. (1991) · PubMed · Cited by 2,526
TGF-β Signaling in Tumor Suppression and Cancer Progression
Derynck, R., Akhurst, R. J., & Balmain, A. (2001) · Nature Genetics · doi:10.1038/ng1001-117 · Cited by 2,275
Bingle, L., Brown, N. J., & Lewis, C. E. (2002) · The Journal of Pathology · doi:10.1002/path.1027 · Cited by 2,022
REGULATION OF IMMUNE RESPONSES BY TGF-β
Letterio, J. J., & Roberts, A. B. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.137 · Cited by 1,890
Cytostatic and apoptotic actions of TGF-β in homeostasis and cancer
Siegel, P. M., & Massagué, J. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1208 · Cited by 1,604
Colony-Stimulating Factor 1 Promotes Progression of Mammary Tumors to Malignancy
Lin, E. Y., Nguyen, A. V., Russell, R. G., & Pollard, J. W. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.6.727 · Cited by 1,594
The role of cyclooxygenases in inflammation, cancer, and development
Williams, C. S., Mann, M., & DuBois, R. N. (1999) · Oncogene · doi:10.1038/sj.onc.1203286 · Cited by 1,417
Barleon, B., Sozzani, S., Zhou, D., Weich, H., Mantovani, A., & Marme, D. (1996) · Blood · doi:10.1182/blood.v87.8.3336.bloodjournal8783336 · Cited by 1,356
Itzkowitz, S. H., & Yio, X. (2004) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00079.2004 · Cited by 1,274
Wyckoff, J., Wang, W., Lin, E. Y., Wang, Y., Pixley, F., Stanley, E. R., Graf, T., Pollard, J. W., Segall, J., & Condeelis, J. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1449 · Cited by 1,188
Prostaglandins as modulators of immunity
Harris, S. G., Padilla, J., Koumas, L., Ray, D., & Phipps, R. P. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(01)02154-8 · Cited by 1,180
The Role of Chemokine Receptors in Primary, Effector, and Memory Immune Responses
Sallusto, F., Mackay, C. R., & Lanzavecchia, A. (2000) · Annual Review of Immunology · doi:10.1146/annurev.immunol.18.1.593 · Cited by 1,041
Interleukin-10 Therapy—Review of a New Approach
Asadullah, K., Sterry, W., & Volk, H. D. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.2.4 · Cited by 946
Murdoch, C., Giannoudis, A., & Lewis, C. E. (2004) · Blood · doi:10.1182/blood-2004-03-1109 · Cited by 915
Schmielau, J., & Finn, O. J. (2001) · PubMed · Cited by 867
Salcedo, R., Ponce, M. L., Young, H. A., Wasserman, K., Ward, J. M., Kleinman, H. K., Oppenheim, J. J., & Murphy, W. J. (2000) · Blood · doi:10.1182/blood.v96.1.34 · Cited by 859
The role of nitric oxide in cancer
XU, W., LIU, L. Z., LOIZIDOU, M., AHMED, M., & CHARLES, I. G. (2002) · Cell Research · doi:10.1038/sj.cr.7290133 · Cited by 826
TGF- β signaling in cancer – a double-edged sword
Akhurst, R. J., & Derynck, R. (2001) · Trends in Cell Biology · doi:10.1016/s0962-8924(01)02130-4 · Cited by 756
Infections as a major preventable cause of human cancer
Kuper, H., Adami, H. ‐., & Trichopoulos, D. (2000) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.2000.00742.x · Cited by 740
Mixed messages: modulation of inflammation and immune responses by prostaglandins and thromboxanes
Tilley, S. L., Coffman, T. M., & Koller, B. H. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13416 · Cited by 725
(2000) · PubMed · Cited by 706
Sitkovsky, M. V., Lukashev, D., Apasov, S., Kojima, H., Koshiba, M., Caldwell, C., Ohta, A., & Thiel, M. (2004) · Annual Review of Immunology · doi:10.1146/annurev.immunol.22.012703.104731 · Cited by 696
Myeloid Suppressor Lines Inhibit T Cell Responses by an NO-Dependent Mechanism
Mazzoni, A., Bronte, V., Visintin, A., Spitzer, J. H., Apolloni, E., Serafini, P., Zanovello, P., & Segal, D. M. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.2.689 · Cited by 690
Nitric oxide synthase activity in human breast cancer
Thomsen, L., Miles, D., Happerfield, L., Bobrow, L., Knowles, R., & Moncada, S. (1995) · British Journal of Cancer · doi:10.1038/bjc.1995.274 · Cited by 626
Chemical basis of inflammation-induced carcinogenesis
Ohshima, H., Tatemichi, M., & Sawa, T. (2003) · Archives of Biochemistry and Biophysics · doi:10.1016/s0003-9861(03)00283-2 · Cited by 620
Menetrier-Caux, C., Montmain, G., Dieu, M. C., Bain, C., Favrot, M. C., Caux, C., & Blay, J. Y. (1998) · Blood · doi:10.1182/blood.v92.12.4778 · Cited by 590
Lee, J.-C., Lee, K.-M., Kim, D.-W., & Heo, D. S. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.12.7335 · Cited by 549
Chronic immune activation and inflammation as the cause of malignancy
O'Byrne, K. J., & Dalgleish, A. G. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2001.1943 · Cited by 543
Mechanisms of TGF-β signaling in regulation of cell growth and differentiation
Moustakas, A., Pardali, K., Gaal, A., & Heldin, C.-H. (2002) · Immunology Letters · doi:10.1016/s0165-2478(02)00023-8 · Cited by 541
Reactive oxygen species in oncogenic transformation
Behrend, L., Henderson, G., & Zwacka, R. M. (2003) · Biochemical Society Transactions · doi:10.1042/bst0311441 · Cited by 531
Steinbrink, K., Jonuleit, H., Müller, G., Schuler, G., Knop, J., & Enk, A. H. (1999) · Blood · doi:10.1182/blood.v93.5.1634 · Cited by 511
Leek, R. D., Landers, R. J., Harris, A. L., & Lewis, C. E. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690158 · Cited by 451
Tumor-induced immune dysfunction: the macrophage connection
Elgert, K. D., Alleva, D. G., & Mullins, D. W. (1998) · Journal of Leukocyte Biology · doi:10.1002/jlb.64.3.275 · Cited by 426
Sica, A., Saccani, A., Bottazzi, B., Polentarutti, N., Vecchi, A., Van Damme, J., & Mantovani, A. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.2.762 · Cited by 426
The intriguing role of polymorphonuclear neutrophils in antitumor reactions
Di Carlo, E., Forni, G., Lollini, P., Colombo, M. P., Modesti, A., & Musiani, P. (2001) · Blood · doi:10.1182/blood.v97.2.339 · Cited by 419
Cyclooxygenase-2: a novel target for cancer chemotherapy?
Dempke, W., Rie, C., Grothey, A., & Schmoll, H.-J. (2001) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s004320000225 · Cited by 419
Microenvironmental influence on macrophage regulation of angiogenesis in wounds and malignant tumors
Crowther, M., Brown, N. J., Bishop, E. T., & Lewis, C. E. (2001) · Journal of Leukocyte Biology · doi:10.1189/jlb.70.4.478 · Cited by 415
Regulation of myeloid development and function by colony stimulating factors
Barreda, D. (2004) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2003.09.010 · Cited by 402
The influence of the microenvironment on the malignant phenotype
Park, C. C., Bissell, M. J., & Barcellos-Hoff, M. H. (2000) · Molecular Medicine Today · doi:10.1016/s1357-4310(00)01756-1 · Cited by 398
Loss of T-cell receptor zeta chain and p56lck in T-cells infiltrating human renal cell carcinoma.
Finke, J. H., Zea, A. H., Stanley, J., Longo, D., Mizoguchi, H., Tubbs, R. R., Wiltrout, R. H., O’Shea, J. J., Kudoh, S., & Klein, E. A. (1993) · PubMed · Cited by 379
Strassmann, G., Patil-Koota, V, Finkelman, F., Fong, M., & Kambayashi, T. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.6.2365 · Cited by 367
Kono, K., Salazar‐Onfray, F., Petersson, M., Hansson, J., Masucci, G., Wasserman, K., Nakazawa, T., Anderson, P., & Kiessling, R. (1996) · European Journal of Immunology · doi:10.1002/eji.1830260620 · Cited by 359
Tumor-Associated Macrophages in Breast Cancer
Leek, R. D., & Harris, A. L. (2002) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1023/a:1020304003704 · Cited by 351
Macarthur, M., Hold, G. L., & El-Omar, E. M. (2004) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00475.2003 · Cited by 348
TCR ζ-chain downregulation: curtailing an excessive inflammatory immune response
Baniyash, M. (2004) · Nature Reviews Immunology · doi:10.1038/nri1434 · Cited by 344
Chemokines: signal lamps for trafficking of T and B cells for development and effector function
Kim, C. H., & Broxmeyer, H. E. (1999) · Journal of Leukocyte Biology · doi:10.1002/jlb.65.1.6 · Cited by 342
Negus, R. P. M., Stamp, G. W. H., Hadley, J., & Balkwill, F. R. (1997) · Europe PMC (PubMed Central) · Cited by 339
Otsuji, M., Kimura, Y., Aoe, T., Okamoto, Y., & Saito, T. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.23.13119 · Cited by 338
Azenshtein, E., Luboshits, G., Shina, S., Neumark, E., Shahbazian, D., Weil, M., Wigler, N., Keydar, I., & Ben‐Baruch, A. (2002) · PubMed · Cited by 335
Self-citationMacrophage infiltration is associated with VEGF and EGFR expression in breast cancer
Leek, R. D., Hunt, N. C., Landers, R. J., Lewis, C. E., Royds, J. A., & Harris, A. L. (2000) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(200003)190:4<430::aid-path538>3.0.co;2-6 · Cited by 322
Induction of inflammatory angiogenesis by monocyte chemoattractant protein-1
Goede, V., Brogelli, L., Ziche, M., & Augustin, H. G. (1999) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19990827)82:5<765::aid-ijc23>3.0.co;2-f · Cited by 319
Negus, R. P., Stamp, G. W., Relf, M. G., Burke, F., Malik, S. T., Bernasconi, S., Allavena, P., Sozzani, S., Mantovani, A., & Balkwill, F. R. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117933 · Cited by 315
Mantovani, A., Allavena, P., & Sica, A. (2004) · European Journal of Cancer · doi:10.1016/j.ejca.2004.03.016 · Cited by 311
Matsuda, M., Salazar, F., Petersson, M., Masucci, G., Hansson, J., Pisa, P., Zhang, Q. J., Masucci, M. G., & Kiessling, R. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.6.2371 · Cited by 306
Friese, M. A., Wischhusen, J., Wick, W., Weiler, M., Eisele, G., Steinle, A., & Weller, M. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1627 · Cited by 305
Luboshits, G., Shina, S., Kaplan, O., Engelberg, S., Nass, D., Lifshitz-Mercer, B., Chaitchik, S., Keydar, I., & Ben‐Baruch, A. (1999) · PubMed · Cited by 302
Self-citationBen-Baruch, A. (2002) · Breast Cancer Research · doi:10.1186/bcr554 · Cited by 300
Self-citationThe Macrophage Growth Factor CSF-1 in Mammary Gland Development and Tumor Progression
Lin, E. Y., Gouon-Evans, V., Nguyen, A. V., & Pollard, J. W. (2002) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1023/a:1020399802795 · Cited by 294
Saji, H., Koike, M., Yamori, T., Saji, S., Seiki, M., Matsushima, K., & Toi, M. (2001) · Cancer · doi:10.1002/1097-0142(20010901)92:5<1085::aid-cncr1424>3.0.co;2-k · Cited by 288
Cytokine regulation of angiogenesis in breast cancer: the role of tumor-associated macrophages
Lewis, C. E., Leek, R., Harris, A., & McGee, J. O. (1995) · Journal of Leukocyte Biology · doi:10.1002/jlb.57.5.747 · Cited by 286
Aharinejad, S., Paulus, P., Sioud, M., Hofmann, M., Zins, K., Schäfer, R., Stanley, E. R., & Abraham, D. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0961 · Cited by 281
Role of nitric oxide in tumour progression: Lessons from human tumours
Thomsen, L. L., & Miles, D. W. (1998) · Cancer and Metastasis Reviews · doi:10.1023/a:1005912906436 · Cited by 276
A chemokine receptor antagonist inhibits experimental breast tumor growth.
Robinson, S. C., Scott, K. A., Wilson, J. L., Thompson, R. G., Proudfoot, A. E. I., & Balkwill, F. R. (2003) · PubMed · Cited by 259
Yue, F. Y., Dummer, R., Geertsen, R., Hofbauer, G. F. L., Laine, E., Manolio, S., & Burg, G. (1997) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19970516)71:4<630::aid-ijc20>3.0.co;2-e · Cited by 257
T Cell-Derived IL-10 Promotes Lung Cancer Growth by Suppressing Both T Cell and APC Function
Sharma, S., Stolina, M., Lin, Y., Gardner, B., Miller, P. W., Kronenberg, M., & Dubinett, S. M. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.9.5020 · Cited by 250
Niwa, Y., Akamatsu, H., Niwa, H., Sumi, H., Ozaki, Y., & Abe, A. (2001) · PubMed · Cited by 245
Ligand-Activation of the Adenosine A2a Receptors Inhibits IL-12 Production by Human Monocytes
Link, A. A., Kino, T., Worth, J. A., McGuire, J. L., Crane, M. L., Chrousos, G. P., Wilder, R. L., & Elenkov, I. J. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.1.436 · Cited by 242
Targeting the TGFβ signaling network in human neoplasia
Dumont, N., & Arteaga, C. L. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00135-1 · Cited by 242
Microenvironmental and cellular consequences of altered blood flow in tumours
Raghunand, N., Gatenby, R. A., & Gillies, R. J. (2003) · The British Journal of Radiology · doi:10.1259/bjr/12913493 · Cited by 240
The emerging role of reactive oxygen species in cancer therapy
Renschler, M. F. (2004) · European Journal of Cancer · doi:10.1016/j.ejca.2004.02.031 · Cited by 237
Tumors and inflammatory infiltrates: Friends or foes?
Brigati, C., Noonan, D. M., Albini, A., & Benelli, R. (2002) · Clinical & Experimental Metastasis · doi:10.1023/a:1015587423262 · Cited by 230
Lai, P., Rabinowich, H., Crowley‐Nowick, P. A., Bell, M. C., Mantovani, G., & Whiteside, T. L. (1996) · PubMed · Cited by 218
Induction of monocyte migration by recombinant macrophage colony-stimulating factor.
Wang, J. M., Griffin, J. D., Rambaldi, A., Chen, Z. G., & Mantovani, A. (1988) · The Journal of Immunology · doi:10.4049/jimmunol.141.2.575 · Cited by 213
Chemokines in the recruitment and shaping of the leukocyte infiltrate of tumors
Mantovani, A., Allavena, P., Sozzani, S., Vecchi, A., Locati, M., & Sica, A. (2004) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2003.10.001 · Cited by 209
Natural mechanisms protecting against cancer
Jakóbisiak, M., Lasek, W., & Gołąb, J. (2003) · Immunology Letters · doi:10.1016/j.imlet.2003.08.005 · Cited by 206
Sombroek, C. C., Stam, A. G. M., Masterson, A. J., Lougheed, S. M., Schakel, M. J. A. G., Meijer, C. J. L. M., Pinedo, H. M., van den Eertwegh, A. J. M., Scheper, R. J., & de Gruijl, T. D. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.9.4333 · Cited by 205
Dinapoli, M. R., Calderon, C. L., & Lopez, D. M. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.4.1323 · Cited by 204
Inflammation and Cancer V. Chronic pancreatitis and pancreatic cancer
Whitcomb, D. C. (2004) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00115.2004 · Cited by 202
Klimp, A. H., Hollema, H., Kempinga, C., van der Zee, A. G. J., de Vries, E. G. E., & Daemen, T. (2001) · PubMed · Cited by 199
Vakkala, M. A., Kahlos, K., Lakari, E., Pääkkö, P. K., Kinnula, V. L., & Soini, Y. (2000) · PubMed · Cited by 196
Qin, Z., Noffz, G., Mohaupt, M., & Blankenstein, T. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.159.2.770 · Cited by 193
Alterations in T cell receptor and signal transduction molecules in melanoma patients.
Zea, A. H., Curti, B. D., Longo, D. L., Alvord, W. G., Strobl, S., Mizoguchi, H., Creekmore, S. P., O’Shea, J. J., Powers, G. C., & Urba, W. J. (1995) · PubMed · Cited by 190
IL-10 inhibits tumor antigen presentation by epidermal antigen-presenting cells.
Beissert, S., Hosoi, J., Grabbe, S., Asahina, A., & Granstein, R. D. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.154.3.1280 · Cited by 184
Direct observation and quantification of macrophage chemoattraction to the growth factor CSF-1
Webb, S. E., Pollard, J. W., & Jones, G. E. (1996) · Journal of Cell Science · doi:10.1242/jcs.109.4.793 · Cited by 179
Jadeski, L. C., & Lala, P. K. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65240-6 · Cited by 174
Shinomiya, S., Naraba, H., Ueno, A., Utsunomiya, I., Maruyama, T., Ohuchida, S., Ushikubi, F., Yuki, K., Narumiya, S., Sugimoto, Y., et al. (2001) · Biochemical Pharmacology · doi:10.1016/s0006-2952(01)00586-x · Cited by 172
TGF-β enhances macrophage ability to produce IL-10 in normal and tumor-bearing mice
Maeda, H., Kuwahara, H., Ichimura, Y., Ohtsuki, M., Kurakata, S., & Shiraishi, A. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.10.4926 · Cited by 167
Yang, A. S., & Lattime, E. C. (2003) · PubMed · Cited by 165
Kono, K., Ressing, M. E., Brandt, R. M. P., Melief, C. J. M., Potkul, R. K., Andersson, B., Petersson, M., Kast, W. M., & Kiessling, R. W. (1996) · PubMed · Cited by 164
Reichert, T. E., Scheuer, C., Day, R., Wagner, W., & Whiteside, T. L. (2001) · Cancer · doi:10.1002/1097-0142(20010601)91:11<2136::aid-cncr1242>3.0.co;2-q · Cited by 162
Dumont, N., & Arteaga, C. L. (2000) · Breast Cancer Research · doi:10.1186/bcr44 · Cited by 158
Down-regulation of ?-chain expression in T cells: a biomarker of prognosis in cancer?
Whiteside, T. L. (2004) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-004-0521-0 · Cited by 151
Tumor Rejection by Disturbing Tumor Stroma Cell Interactions
Ibe, S., Qin, Z., Schüler, T., Preiß, S., & Blankenstein, T. J. F. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.11.1549 · Cited by 149
Malmberg, K. (2004) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-004-0577-x · Cited by 147
Reichert, T. E., Day, R., Wagner, E. M., & Whiteside, T. L. (1998) · PubMed · Cited by 147
Yu, J. L., & Rak, J. W. (2003) · Breast Cancer Research · doi:10.1186/bcr573 · Cited by 146
Kacinski, B. M., Carter, D., Mittal, K., Yee, L. D., Scata, K. A., DONOFRIO, L. M., Chambers, S. K., Wang, K. I., Yang‐Feng, T. L., & Rohrschneider, L. R. (1990) · Europe PMC (PubMed Central) · Cited by 145
Activated macrophages induce structural abnormalities of the T cell receptor-CD3 complex.
Aoe, T., Okamoto, Y., & Saito, T. (1995) · The Journal of Experimental Medicine · doi:10.1084/jem.181.5.1881 · Cited by 145
Tumor-associated macrophage (TAM) infiltration in gastric cancer.
Ishigami, S., Natsugoe, S., Tokuda, K., Nakajo, A., Okumura, H., Matsumoto, M., Miyazono, F., Hokita, S., & Aikou, T. (2003) · PubMed · Cited by 138
Expression of monocyte chemotactic protein-1 in human invasive ductal breast cancer
Valković, T., Lučin, K., Krstulja, M., Dobi-Babić, R., & Jonjić, N. (1998) · Pathology - Research and Practice · doi:10.1016/s0344-0338(98)80057-5 · Cited by 137
Endothelin-2 is a macrophage chemoattractant: implications for macrophage distribution in tumors
Grimshaw, M. J., Wilson, J. L., & Balkwill, F. R. (2002) · European Journal of Immunology · doi:10.1002/1521-4141(200209)32:9<2393::aid-immu2393>3.0.co;2-4 · Cited by 135
Yamashiro, S., Takeya, M., Nishi, T., Kuratsu, J. I., Yoshimura, T., Ushio, Y., & Takahashi, K. (1994) · PubMed Central · Cited by 132
Monocyte Chemoattractant Protein-1 Serum Levels in Patients with Breast Cancer
Lebrecht, A., Grimm, C., Lantzsch, T., Ludwig, E., Hefler, L., Ulbrich, E. J., & Koelbl, H. (2004) · Tumor Biology · doi:10.1159/000077718 · Cited by 131
Immunodeficiency and cancer: prospects for correction
Hadden, J. W. (2003) · International Immunopharmacology · doi:10.1016/s1567-5769(03)00060-2 · Cited by 131
Reversal of Tumor-induced Immunosuppression by TGF-β Inhibitors
Wojtowicz‐Praga, S. (2003) · Investigational New Drugs · doi:10.1023/a:1022951824806 · Cited by 123
Tumor-associated macrophages: a molecular perspective
Sica, A., Saccani, A., & Mantovani, A. (2002) · International Immunopharmacology · doi:10.1016/s1567-5769(02)00064-4 · Cited by 123
Inflammation as Cause for Scar Cancers of the Lung
Ardies, C. M. (2003) · Integrative Cancer Therapies · doi:10.1177/1534735403256332 · Cited by 120
Tumor-Derived TGF-β Reduces the Efficacy of Dendritic Cell/Tumor Fusion Vaccine
Kao, J. Y., Gong, Y., Chen, C.-M., Zheng, Q.-D., & Chen, J. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.7.3806 · Cited by 119
Inflammation and Cancer: An Epidemiological Perspective
Thun, M. J., Henley, S. J., & Gansler, T. S. (2004) · Novartis Foundation symposium · doi:10.1002/0470856734.ch2 · Cited by 119
Hypoxia inhibits macrophage migration
Turner, L., Scotton, C. J., Negus, R. P. M., & Balkwill, F. R. (1999) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199907)29:07<2280::aid-immu2280>3.0.co;2-c · Cited by 118
Paracrine angiogenic loop between head-and-neck squamous-cell carcinomas and macrophages
Liss, C., Fekete, M. J., Hasina, R., Lam, C. D., & Lingen, M. W. (2001) · International Journal of Cancer · doi:10.1002/ijc.1407 · Cited by 114
Kaliński, P., Hilkens, C. M. U., Snijders, A. J., Snijdewint, F. G. M., & Kapsenberg, M. L. (1997) · Advances in experimental medicine and biology · doi:10.1007/978-1-4757-9966-8_59 · Cited by 110
Autocrine CSF-1R activation promotes Src-dependent disruption of mammary epithelial architecture
Wrobel, C. N., Debnath, J., Lin, E., Beausoleil, S. A., Roussel, M. F., & Brugge, J. S. (2004) · The Journal of Cell Biology · doi:10.1083/jcb.200309102 · Cited by 106
Role of TGF-? in immune-evasion of cancer
Beck, C., Schreiber, H. W., & Rowley, D. A. (2001) · Microscopy Research and Technique · doi:10.1002/1097-0029(20010215)52:4<387::aid-jemt1023>3.0.co;2-w · Cited by 106
The Role of CSF-1 in Normal Physiology of Mammary Gland and Breast Cancer: An Update
Sapi, E. (2004) · Experimental Biology and Medicine · doi:10.1177/153537020422900101 · Cited by 104
Interleukin-10: a cytokine used by tumors to escape immunosurveillance
Salazar‐Onfray, F. (1999) · Medical Oncology · doi:10.1007/bf02785841 · Cited by 104
Origin and regulation of tumor-associated macrophages: the role of tumor-derived chemotactic factor
Mantovani, A., Ming, W. J., Balotta, C., Benomar, A., & Bottazzi, B. (1986) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(86)90013-2 · Cited by 102
In situ cytokine production by breast cancer tumor-infiltrating lymphocytes
Camp, B. J., Dyhrman, S. T., Memoli, V. A., Mott, L. A., & Barth, R. J. (1996) · Annals of Surgical Oncology · doi:10.1007/bf02305798 · Cited by 99
Expression of the macrophage colony-stimulating factor and its receptor in gynecologic malignancies
Baiocchi, G., Talpaz, M., Gutterman, J. U., Kurzrock, R., Kavanagh, J. J., & Wharton, J. T. (1991) · Cancer · Cited by 98
Tang, R., Ojeda‐Uribe, M., Pouillart, P., Scholl, S., Beuvon, F., & Mosseri, V. (1992) · Journal of Cellular Biochemistry · doi:10.1002/jcb.240500403 · Cited by 98
Angiogenesis and inflammation in invasive carcinoma of the breast.
Lee, A. H., Happerfield, L. C., Bobrow, L. G., & Millis, R. R. (1997) · Journal of Clinical Pathology · doi:10.1136/jcp.50.8.669 · Cited by 95
Inflammation as a Target for Prostate Cancer Chemoprevention: Pathological and Laboratory Rationale
Lucia, M. S., & Torkko, K. C. (2004) · The Journal of Urology · doi:10.1097/01.ju.0000108142.53241.47 · Cited by 95
Cytokine deregulation in cancer
Kurzrock, R. (2001) · Biomedicine & Pharmacotherapy · doi:10.1016/s0753-3322(01)00140-8 · Cited by 94
Walker, R. A., Dearing, S. J., & Gallacher, B. (1994) · British Journal of Cancer · doi:10.1038/bjc.1994.228 · Cited by 92
Hypoxia Selectively Inhibits Monocyte Chemoattractant Protein-1 Production by Macrophages
Bosco, M. C., Puppo, M., Pastorino, S., Mi, Z., Melillo, G., Massazza, S., Rapisarda, A., & Varesio, L. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.3.1681 · Cited by 92
Analysis of CC chemokine and chemokine receptor expression in solid ovarian tumours
Scotton, C. J., Milliken, D., Wilson, J. L., Raju, S., & Balkwill, F. R. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2001.2020 · Cited by 91
García-Hernández, M. D. L. L., Hernández‐Pando, R., Gariglio, P., & Berumen-Campos, J. (2002) · Immunology · doi:10.1046/j.1365-2567.2002.01363.x · Cited by 91
Hypoxia down-regulates MCP-1 expression: implications for macrophage distribution in tumors
Negus, R. P. M., Turner, L., Burke, F., & Balkwill, F. R. (1998) · Journal of Leukocyte Biology · doi:10.1002/jlb.63.6.758 · Cited by 91
Salazar‐Onfray, F., Charo, J., Petersson, M., Freland, S., Noffz, G., Qin, Z., Blankenstein, T., Ljunggren, H., & Kiessling, R. W. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.159.7.3195 · Cited by 89
A dual role for tumor-derived chemokine RANTES (CCL5)
Adler, E. P., Lemken, C. A., Katchen, N. S., & Kurt, R. A. (2003) · Immunology Letters · doi:10.1016/j.imlet.2003.09.013 · Cited by 89
Circulating macrophage colony stimulating factor as a marker of tumour progression.
McDermott, R., Deneux, L., Mosseri, V., Vedrenne, J., Clough, K. B., Fourquet, A., Rodríguez, J. L. V., Cosset, J., Sastre‐Garau, X., Beuzeboc, P., et al. (2002) · PubMed · Cited by 85
Tumour escape: antitumour effectors too much of a good thing?
Pawelec, G. (2004) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-003-0469-5 · Cited by 85
Duyndam, M. C. A., Hilhorst, M. C. G. W., Schlüper, H. M. M., Verheul, H. M. W., van Diest, P. J., Kraal, G., Pinedo, H. M., & Boven, E. (2002) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64873-0 · Cited by 84
Smad3 Knockout Mice Exhibit a Resistance to Skin Chemical Carcinogenesis
Li, A. G., Lu, S., Zhang, M., Deng, C., & Wang, X. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1331 · Cited by 82
Schwartsburd, P. M. (2003) · Cancer and Metastasis Reviews · doi:10.1023/a:1022220219975 · Cited by 81
Prostaglandins and the Regulation of Tumor Growth
Bishop‐Bailey, D., Calatayud, S., Warner, T. D., et al. (2002) · Journal of Environmental Pathology Toxicology and Oncology · doi:10.1615/jenvironpatholtoxicoloncol.v21.i2.20 · Cited by 76
Locati, M., Otero, K., Schioppa, T., Signorelli, P., Perrier, P., Baviera, S., Sozzani, S., & Mantovani, A. (2002) · Allergy · doi:10.1034/j.1398-9995.2002.02166.x · Cited by 75
Endothelin-2 is a hypoxia-induced autocrine survival factor for breast tumor cells.
Grimshaw, M. J., Naylor, S., & Balkwill, F. R. (2002) · PubMed · Cited by 74
(2000) · doi:10.1002/1096-9896(2000)9999:9999 · Cited by 70
Watson, G. A., Fu, Y., & Lopez, D. M. (1991) · Journal of Leukocyte Biology · doi:10.1002/jlb.49.2.126 · Cited by 67
Scholl, S., Lidereau, R., de la Rochefordière, A., Le-Nir, C. C.-S., Mosseri, V., Noguès, C., Pouillart, P., & Stanley, E. R. (1996) · Breast Cancer Research and Treatment · doi:10.1007/bf01806155 · Cited by 62
Mitsuhashi, M., Liu, J., Cao, S., Shi, X., & Ma, X. (2004) · Journal of Leukocyte Biology · doi:10.1189/jlb.1203641 · Cited by 62
Neumark, E., Sagi‐Assif, O., Shalmon, B., et al. (2003) · International Journal of Cancer · doi:10.1002/ijc.11337 · Cited by 61
Tumour-associated macrophages in breast cancer and their prognostic correlations
Volodko, N., Reiner, A., Rudas, M., & Jakesz, R. (1998) · The Breast · doi:10.1016/s0960-9776(98)90065-0 · Cited by 53
Monocyte chemoattractant protein inhibits the generation of tumor-reactive T cells.
Peng, L., Shu, S., & Krauss, J. C. (1997) · PubMed · Cited by 51
Regulation of the trafficking of tumour-infiltrating dendritic cells by chemokines
Vicari, A. P., Treilleux, I., & Lebecque, S. (2004) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2003.10.002 · Cited by 51
Impact of tumor-derived CCL2 on T cell effector function
Vitiello, P. F., Shainheit, M. G., Allison, E. M., Adler, E. P., & Kurt, R. A. (2004) · Immunology Letters · doi:10.1016/j.imlet.2003.12.009 · Cited by 46
Immune responses to human tumors: development of tumor vaccines.
Platsoucas, C. D., Fincke, J. E., Pappas, J., Jung, W.-J., Heckel, M. C., Schwarting, R., Magira, E. E., Monos, D. S., & Freedman, R. S. (2003) · PubMed · Cited by 45
Carlo, E. D., Cappello, P., Sorrentino, C., D’Antuono, T., Pellicciotta, A., Giovarelli, M., Forni, G., Musiani, P., & Triebel, F. (2004) · The Journal of Pathology · doi:10.1002/path.1679 · Cited by 44
Kirma, N. B., Luthra, R., Jones, J., Liu, Y.-G., Nair, H. B. B., Mandava, U., & TEKMAL, R. R. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2971 · Cited by 43
Comes, A., Carlo, E. D., Musiani, P., Rosso, O., Meazza, R., Chiodoni, C., Colombo, M. P., & Ferrini, S. (2002) · European Journal of Immunology · Cited by 42
Neumark, E., Anavi, R., Witz, I. P., & Ben‐Baruch, A. (1999) · Immunology Letters · doi:10.1016/s0165-2478(99)00043-7 · Cited by 39
Self-citationde Bittencourt, P. I. H., & Curi, R. (2001) · Biochemical Pharmacology · doi:10.1016/s0006-2952(01)00738-9 · Cited by 35
Tsuruma, T., Yagihashi, A., Torigoe, T., Sato, N., Kikuchi, K., Watanabe, N., & Hirata, K. (1998) · Cellular Immunology · doi:10.1006/cimm.1998.1266 · Cited by 34
Liss, C., Fekete, M. J., Hasina, R., & Lingen, M. W. (2002) · International Journal of Cancer · doi:10.1002/ijc.10507 · Cited by 31
Ovarian expression of chemokines and their receptors
Zhou, C., Borillo, J., Wu, J. G., Torres, L. K., & Lou, Y. (2004) · Journal of Reproductive Immunology · doi:10.1016/j.jri.2004.03.002 · Cited by 31
Merendino, R. A., Gangemi, S., Misefari, A., et al. (1999) · Immunology Letters · doi:10.1016/s0165-2478(99)00067-x · Cited by 27
Tsuruma, T., Yagihashi, A., Hirata, K., Torigoe, T., Araya, J., Watanabe, N., & Sato, N. (1999) · Cellular Immunology · doi:10.1006/cimm.1999.1586 · Cited by 23
Mouri, H., Sakaguchi, K., Sawayama, T., Senoh, T., Ohta, T., Nishimura, M., Fujiwara, A., Terao, M., Shiratori, Y., & Tsuji, T. (2002) · PubMed · doi:10.18926/amo/31688 · Cited by 23
Baron, C. L., Raposo, G., Scholl, S., Bausinger, H., Tenza, D., Bohbot, A., Pouillart, P., Goud, B., Hanau, D., & Salamero, J. (2001) · Journal of Cell Science · doi:10.1242/jcs.114.5.999 · Cited by 22
Takahashi, A., Kono, K., Ichihara, F., Sugai, H., Amemiya, H., Iizuka, H., Fujii, H., & Matsumoto, Y. (2003) · International Journal of Cancer · doi:10.1002/ijc.10973 · Cited by 20
Possible co-regulation of genes associated with enhanced progression of mammary adenocarcinomas
Neumark, E., Cohn, M. A., Lukanidin, E. M., Witz, I. P., & Ben‐Baruch, A. (2002) · Immunology Letters · doi:10.1016/s0165-2478(02)00026-3 · Cited by 19
Self-citationAge-Dependent Alterations in the Tumoricidal Functions of Tumor-Associated Macrophages
Khare, V., Sodhi, A., & Singh, S. M. (1999) · Tumor Biology · doi:10.1159/000056519 · Cited by 10
Ben‐Baruch, A. (2005) · Springer eBooks · doi:10.1007/1-4020-3414-8_11 · Cited by 9
Self-citationp53 gene mutations and 17p allelic deletions in hepatocellular carcinoma from Japan
Nose, H., Imazeki, F., Ohto, M., & Omata, M. (1993) · Cancer · doi:10.1002/1097-0142(19930715)72:2
Cited by
The senescence-associated secretory phenotype: the dark side of tumor suppression
Coppé, J.-P., Desprez, P.-Y., Krtolica, A., & Campisi, J. (2010) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-121808-102144 · Cited by 5,206
Distinct role of macrophages in different tumor microenvironments
Lewis, C. E., & Pollard, J. W. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4005 · Cited by 2,225
A cytokine-mediated link between innate immunity, inflammation, and cancer
Lin, W.-W., & Karin, M. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31537 · Cited by 1,940
Validating matrix metalloproteinases as drug targets and anti-targets for cancer therapy
Overall, C. M., & Kleifeld, O. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1821 · Cited by 1,214
Macrophages in Tumor Microenvironments and the Progression of Tumors
Hao, N.-B., Lü, M.-H., Fan, Y.-H., Cao, Y.-L., Zhang, Z.-R., & Yang, S.-M. (2012) · Clinical and Developmental Immunology · doi:10.1155/2012/948098 · Cited by 1,003
Metadata
- Authors
- BENBARUCH, A.
- Venue
- Seminars in Cancer Biology
- Publisher
- Elsevier BV
- Published
- 2006-02
- Volume
- 16
- Issue
- 1
- Pages
- 38-52
- ISSN
- 1044-579X (ISSN-L)
- OpenAlex
- W1983591605
- Cited by
- 335
- References
- 174
- FWCI
- 5.47
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.